Xiangya Hospital Of Central South University

This study is testing an already-approved eczema medication called ivarmacitinib in a real-world setting. It will enroll 1000 adolescents and adults with moderate-to-severe atopic dermatitis to see how well it controls itching, clears skin rashes, and prevents flare-ups. The main…

This study is testing whether adding a cholesterol-lowering drug (recaticimab) to a standard psoriasis medication (vunakizumab) works better for people who have both conditions. It will involve 40 adults with moderate-to-severe plaque psoriasis and high cholesterol. The main goal…

This study aims to see if a combination of two drugs (camrelizumab and rivoceranib), with or without local treatments like surgery or radiation, can help control advanced liver cancer that has spread to the lungs. It will involve 32 adults who have not had prior treatment for the…

This study is testing if adding a brain-protecting drug (butylphthalide) to a standard clot-dissolving medicine (tenecteplase) helps people recover better after a mild but disabling stroke. Over 1,000 participants who have a stroke with mild symptoms but still have trouble with s…

This study aims to find a safer way to measure dangerous pressure inside the skull after a head injury. Researchers will test if a simple bedside ultrasound scan on the eye and head is as accurate as the current method, which requires surgery to place a monitor. The goal is to pr…

This study aims to develop a faster, more accurate blood test to determine if tissue death in severe pancreatitis has become infected. Researchers will test 200 patients across four hospitals using a combination of two advanced blood analysis techniques. If successful, this test …

This study aims to see if using a common intravenous pain medication (acetaminophen) is better than a stronger opioid (sufentanil) at preventing confusion and delirium in older patients after non-heart surgery. It will involve over 1,000 patients aged 60+ in intensive care units …

This study is testing if a new pain medication called tegileridine helps people recover faster after abdominal surgery. Researchers want to see if it helps patients' bowels start working again sooner than the standard morphine, allowing them to eat solid food and pass gas more qu…

This large observational study aims to better understand how atrial fibrillation (an irregular heart rhythm) and common metabolic disorders like obesity and diabetes interact in Chinese patients. Researchers will follow 3,459 participants over time to track health outcomes, quali…